After gallstone surgery in China: recovery timelines, post-op issues, and the recurrence question
Our first guide covered how to choose — removal vs gallbladder-preserving stone removal, and what each actually costs. This one covers what happens after: how fast you recover, the two things patients actually worry about (diarrhoea after removal, recurrence after preservation), what the research really says, and the three questions to ask any program in writing before you book.
Both routes — laparoscopic removal and gallbladder-preserving stone removal — are minimally-invasive keyhole operations. For the removal route the timeline is well documented by hospitals and surgical bodies; for preservation, expect a similar minimally-invasive recovery, since the incision pattern is the same (most programs quote comparable stays — confirm the exact plan in writing).
| Milestone | Laparoscopic removal | Gallbladder-preserving removal |
|---|---|---|
| Hospital stay | Same-day discharge is routine at day-surgery centres; sometimes one nightBeijing Friendship Hospital (national centre for digestive disease): day-surgery, home the same day (Aug 2026) [1]; Mayo Clinic: home same day or one night [2] | Comparable minimally-invasive stay — confirm the program's package in writingMost preservation programs quote 1–3 nights; verify before booking — this is part of the written-quote check in our first guide. |
| Getting moving | Out of bed 2–4 hours after surgery; clear fluids from day oneBeijing Friendship Hospital [1] | Same keyhole recovery pattern |
| Normal daily activity | About 1 week for full recovery; most people resume normal life within 1–2 weeksMayo Clinic: about a week to fully recover [2]; Beijing Friendship Hospital: 1–2 weeks for most patients [1] | Same expectation — organ kept, which is the point |
| Returning to work | Typically 10–14 days for desk work; heavy manual work may need 2–4 weeksRoyal College of Surgeons of England: usually safe at 10–14 days [3] | Ask the program what their patients average — put it in writing |
Two practical notes for overseas patients: book your return flight accordingly (same-week returns are possible for desk workers, but do not plan heavy travel for at least the first week), and get the discharge summary and imaging in English before you leave the hospital — the same unit/reference-range discipline as our first guide's checklist.
A minority get loose stools; most settle
Post-cholecystectomy diarrhoea is common enough to be a named syndrome (bile-acid diarrhoea): reviews estimate 5–12% of patients develop diarrhoea after the operationUS review estimating 5–12% of ~750,000 annual cholecystectomies [4], with reported ranges across studies spanning 2.1–57.2% depending on definitionUK multicentre audit of post-cholecystectomy diarrhoea rates [5].
The mechanism: without the gallbladder, bile trickles into the bowel more continuously, and some people's colon absorbs it poorly. Most cases are mild and settle within weeks. Persistent cases are treatable with a bile-acid binder (cholestyramine / colesevelam) — ask for it in writing if you're affected.Diagnosis & treatment of post-cholecystectomy diarrhoea [4]
Real, and the honest caveat of the whole route
Preservation keeps your organ, but your bile chemistry that formed stones in the first place usually doesn't change. Published recurrence figures vary enormously — from 2.7–4.1% at 1–6 years in one large Chinese series895 patients, Journal of Chinese Endoscopy 2002, via Chinese press review [11], to 41.5% over 10 years in another439 patients, 10-year follow-up, 2007 [8]. More recent studies sit between: 9.7% (145 patients, ~36 months median follow-up)[6] and 16.1% at 36 months in a small series36 patients [9].
That spread is the whole point: recurrence depends on who gets operated on and how strict the eligibility gates are — which is why the next section matters more than any single number.
The honest answer: it depends on patient selection, and you can predict your own risk before you fly. Published studies cluster into two worlds:
- The low-recurrence series (2.7–4.1% over 1–6 years, 895 patients, 2002)[11] come from centres that screen hard — good gallbladder function, single or few stones, thin walls — the exact gates our first guide lists.
- The high-recurrence series (up to 41.5% over 10 years)439 patients, 10-year follow-up; recurrence peaked at year 5–6 [8] reflect broader patient selection and longer follow-up windows. A 145-patient study with ~36-month follow-up landed at 9.7%, with recurrence typically appearing about 30 months out[6].
What independently predicts recurrence in a prospective single-centre study: multiple stones, a gallbladder wall ≥ 4 mm, and a family history of gallstonesProspective study, laparoscopy + choledochoscopic lithotomy, 5.71% overall [10]. Notice those are exactly the eligibility gates in our first guide — a reputable surgeon should decline preservation for you if you carry them.
- Chinese national surgical guidance takes the removal side. The recent expert consensus in the Chinese Journal of Surgery states cholecystectomy is the only curative treatment for benign gallbladder disease and explicitly argues against gallbladder-preserving stone removal for stonesExpert consensus via Chinese press review, incl. citing EASL and Tokyo 2018 guidelines not listing preservation [11].
- No major international guideline lists preservation as a standard option. EASL and the Tokyo guidelines don't cover it; the 2020 WSES guideline recommends laparoscopic cholecystectomy as first-line for acute calculous cholecystitis[11].
- Why preservation exists then: patient preference for keeping the organ, mostly in China and Japan, where the technique has real volume and specialist expertise. The debate is live. Your job is not to win it — it's to get your risk factors assessed honestly, and to walk away if a program says "no problem" without imaging.
Ursodeoxycholic acid (UDCA) is the drug most Chinese preservation programs use after surgery to reduce recurrence — it makes bile less cholesterol-saturated, which is the whole point of keeping a stone-forming organ.
Dose. For gallstone dissolution the standard is 8–10 mg per kg per day, in divided dosesStatPearls: 8–10 mg/kg/day divided into 3–4 doses [12]; FDA ursodiol labelling: 8–10 mg/kg/day [13]. For prevention after rapid weight loss, FDA labelling uses 600 mg/day (300 mg twice daily)[13]. Some preservation programs run 500–1,000 mg/day after surgery — ask for the exact drug, dose and duration in writing.
Evidence level. UDCA's effect on gallstone dissolution is well documented (reported dissolution in 30–60% of selected radiolucent stones)UDCA review [14]. As post-operative prevention after preservation surgery, the evidence is thinner and mixed — which is exactly why you want the protocol, the follow-up imaging schedule and the recurrence rate of that program, not a marketing line.
One more honest note: UDCA doesn't fix a poorly selected patient. If your imaging shows thick walls, sludge or multiple stones, no amount of post-op drug makes preservation a good bet — removal is the better conversation.
- "What is your recurrence rate, over how many patients and how long, and what definition?" You want their own follow-up data, not a national figure. A program that can't produce one hasn't tracked outcomes — walk away.
- "What exactly is the post-op protocol?" UDCA or not, drug name, dose, duration; diet guidance; and what the imaging follow-up schedule is (which months, which scan).
- "What happens if stones return after I'm home?" Who to contact, whether remote advice is available, whether a revision (e.g. delayed removal) is covered in the package, and what it costs.
- Red flags that mean urgent care, not a wait: fever, vomiting, jaundice (yellow skin/eyes), or pain that is worse than your pre-op attacks — go to your local ER and contact the surgical team with your English discharge summary in hand.
- Routine follow-up: the program's imaging schedule (commonly an ultrasound around 3–6 months after preservation, then annually). If you can't travel back, arrange the scan at home and send the English report to the surgical team.
- Keep the paper trail: discharge summary, operation note, pathology report (if any) and imaging in English with units and reference ranges — the same discipline as our first guide's checklist.
- Beijing Friendship Hospital / National Clinical Research Center for Digestive Diseases: "科学认识胆囊切除手术" patient education (Aug 2026) — day-surgery discharge, 2–4h mobilisation, 1–2 weeks recovery
- Mayo Clinic: Cholecystectomy — after the procedure — same-day or one-night stay; about a week to full recovery
- The Royal College of Surgeons of England: "Get Well Soon" — gall bladder removal — return to work 10–14 days
- PMC: Diagnosis and treatment of post-cholecystectomy diarrhoea — review estimating 5–12% incidence
- PMC: Rates of bile acid diarrhoea after cholecystectomy — a multicentre audit — reported range 2.1–57.2%
- PMC: Reconsideration of indications for choledochoscopic gallbladder-preserving surgery and preventive measures for postoperative recurrence — 14/145 (9.7%) recurrence, mean ~30 months
- ChinaMed Navigator: Gallbladder surgery in China: the middle path, real costs, and how to choose — eligibility gates and verified cost anchors
- PubMed: Gallstone recurrence after successful percutaneous cholecystolithotomy — 10-year follow-up of 439 cases — 41.46% overall recurrence
- PMC: Transcystic gallbladder-preserving cholecystolithotomy — retrospective single-centre study — 16.13% recurrence at 36 months
- PMC: Risk factors for early recurrence of gallstones after laparoscopy combined with choledochoscopic lithotomy — prospective study — 5.71% overall; risk factors: multiple stones, wall ≥ 4 mm, family history
- Life Times (生命时报), Chinese press review citing Journal of Chinese Endoscopy 2002 (895 patients, 2.7–4.1% at 1–6 years), Hepatology 1997 (~20% at 1–5 years), Chinese Journal of Surgery expert consensus, EASL / Tokyo 2018 / WSES 2020 guideline positions: 胆结石该不该保胆?
- NCBI Bookshelf — StatPearls: Ursodeoxycholic Acid — 8–10 mg/kg/day dissolution; 300 mg twice daily prophylaxis
- FDA: Ursodiol Capsules USP (300 mg) — approved labelling — 8–10 mg/kg/day; 600 mg/day (300 mg b.i.d.) for prevention
- PMC: Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed — dissolution 30–60% in selected stones; 8–10 mg/kg/day
- ChinaMed Navigator: What healthcare actually costs in China — diagnostic benchmarks
Want a program's recurrence protocol checked before you book?
We verify hospitals and departments against official disclosures — tell us the procedure, the city (Shenzhen, Guangzhou or Hong Kong), and your imaging results, and we'll tell you exactly what to ask for in writing, and whether preservation is even the right conversation for you. No sales call, no obligation — sometimes the honest answer is not to come.